Accéder directement au contenu Accéder directement à la navigation
Autre publication

Indian Pharma: A Global Leader Under Pressure

Abstract : India is a global supplier of generic drugs. Its export-oriented pharmaceutical industry is extremely profitable but encounters a number of challenges, from domestic demand to human resources. The Covid-19 pandemic has brought to light its dependence on imports from China of active pharmaceutical ingredients and chemical intermediates. As the whole world discusses how to increase the resilience of supply chains, could this be an opportunity for a Europe-India cooperation? This is the theme of the last article of our new series on India’s health sector, by Christophe Jaffrelot, Senior Research Fellow at CERI-SciencesPo/CNRS, Vihang Jumle, Project Officer at TRAFFIC WWF India and Maitreyee Kishor, a Sciences Po graduate who works at Ashoka University's Centre for Writing and Communication.
Type de document :
Autre publication
Liste complète des métadonnées
Contributeur : Spire Sciences Po Institutional Repository <>
Soumis le : mardi 10 novembre 2020 - 16:40:17
Dernière modification le : vendredi 2 juillet 2021 - 13:59:53




Christophe Jaffrelot, Vihang Jumle, Maitreyee Kishor. Indian Pharma: A Global Leader Under Pressure. 2020. ⟨hal-02998833⟩



Consultations de la notice